High density lipoprotein stimulated migration of macrophages depends on the scavenger receptor class B, type I, PDZK1 and Akt1 and is blocked by sphingosine 1 phosphate receptor antagonists

PLoS One. 2014 Sep 4;9(9):e106487. doi: 10.1371/journal.pone.0106487. eCollection 2014.

Abstract

HDL carries biologically active lipids such as sphingosine-1-phosphate (S1P) and stimulates a variety of cell signaling pathways in diverse cell types, which may contribute to its ability to protect against atherosclerosis. HDL and sphingosine-1-phosphate receptor agonists, FTY720 and SEW2871 triggered macrophage migration. HDL-, but not FTY720-stimulated migration was inhibited by an antibody against the HDL receptor, SR-BI, and an inhibitor of SR-BI mediated lipid transfer. HDL and FTY720-stimulated migration was also inhibited in macrophages lacking either SR-BI or PDZK1, an adaptor protein that binds to SR-BI's C-terminal cytoplasmic tail. Migration in response to HDL and S1P receptor agonists was inhibited by treatment of macrophages with sphingosine-1-phosphate receptor type 1 (S1PR1) antagonists and by pertussis toxin. S1PR1 activates signaling pathways including PI3K-Akt, PKC, p38 MAPK, ERK1/2 and Rho kinases. Using selective inhibitors or macrophages from gene targeted mice, we demonstrated the involvement of each of these pathways in HDL-dependent macrophage migration. These data suggest that HDL stimulates the migration of macrophages in a manner that requires the activities of the HDL receptor SR-BI as well as S1PR1 activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Cell Movement / drug effects
  • Cells, Cultured
  • Fingolimod Hydrochloride
  • Intracellular Signaling Peptides and Proteins / genetics
  • Intracellular Signaling Peptides and Proteins / metabolism*
  • Lipoproteins, HDL / pharmacology*
  • Macrophages / cytology*
  • Macrophages / drug effects
  • Macrophages / metabolism*
  • Membrane Proteins
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Oxadiazoles / pharmacology
  • Pertussis Toxin / pharmacology
  • Propylene Glycols / pharmacology
  • Proto-Oncogene Proteins c-akt / genetics
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Receptors, Lysosphingolipid / agonists
  • Receptors, Lysosphingolipid / antagonists & inhibitors
  • Receptors, Lysosphingolipid / metabolism*
  • Scavenger Receptors, Class B
  • Sphingosine / analogs & derivatives
  • Sphingosine / pharmacology
  • Thiophenes / pharmacology

Substances

  • Intracellular Signaling Peptides and Proteins
  • Lipoproteins, HDL
  • Membrane Proteins
  • Oxadiazoles
  • PDZK1 protein, mouse
  • Propylene Glycols
  • Receptors, Lysosphingolipid
  • SEW2871
  • Scarb1 protein, mouse
  • Scavenger Receptors, Class B
  • Thiophenes
  • Pertussis Toxin
  • Akt1 protein, mouse
  • Proto-Oncogene Proteins c-akt
  • Fingolimod Hydrochloride
  • Sphingosine

Grants and funding

This research was supported by a grant in aid (T 7239) and a Program Grant (PRG 6502) from the Heart and Stroke Foundation of Canada. AA is a recipient of a graduate scholarship from Kuwait University, Faculty of Medicine. LG is a recipient of a graduate scholarship from the Equal Opportunities Canada-Chile Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.